Premier Inc.
04/01/2026 | Press release | Archived content
Judge Voids HHS Policy Limiting Hospital Discount Drug Purchases
*:last-child]:mb-0 [&>*:last-child]:pb-0 [&>p]:font-normal text-left [&>.prm-button-bar]:justify-start [&_.portable-text-link]:font-semibold [&_.portable-text-link]:underline [&_.prm-button-bar_a]:no-underline [&_li]:text-light-gray [&_p]:text-light-gray">
Bloomberg Law covers a federal court ruling vacating a 2013 Health Resources and Services Administration (HRSA) policy that restricted hospitals from purchasing drugs through both the 340B discount program and group purchasing organizations. The decision, issued by the U.S. District Court for the District of Columbia, found the policy lacked sufficient justification and ruled in favor of Premier Inc., which challenged the restriction. The ruling could impact how hospitals manage drug purchasing strategies within the 340B program.
Read the full story on Bloomberg Law.
Premier Inc. published this content on April 01, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 08, 2026 at 16:12 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]